05:23 PM EDT, 05/14/2024 (MT Newswires) -- Harry Sloan, Director, on May 14, 2024, executed a purchase for 297,619 shares in Ginkgo Bioworks Holdings ( DNA ) for $271,815. Following the Form 4 filing with the SEC, Sloan has control over a total of 718,540 shares of the company, with 718,540 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1830214/000112760224015300/xslF345X03/form4.xml

Price: 0.8850, Change: +0.02, Percent Change: +2.57